The global drugs for vulvovaginal candidiasis market is experiencing consistent growth, driven by increasing awareness of women’s health issues and rising prevalence of fungal infections. According to The Insight Partners, the market is projected to expand steadily during the forecast period from 2025 to 2031.
Vulvovaginal candidiasis (VVC), commonly known as a yeast infection,...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt